Citius Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Citius Pharmaceuticals, Inc. (CTXR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 40.40 thousand shares for the 12-month period ending 2024-09-30, per its 10-K filed 2024-12-27.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2024-12-27
- Citius Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2024-09-30 was -452.88K shares, a 703.85% decline year-over-year.
- Citius Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2024-06-30 was 144.94K shares.
- Citius Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2023-09-30 was 75.00K shares.
- Citius Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 40.40K shares, a 79.63% decline from fiscal 2023.
- Citius Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 198.33K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2024-09-30 | -452.88K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-27 | -307.94K shares derived: sum of 2 quarters · filed 2024-12-27 | 40.40K shares 10-K · filed 2024-12-27 | |
| 2024-06-30 | 144.94K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-12 | 493.28K shares 10-Q · filed 2024-08-12 | ||
| 2024-03-31 | 348.34K shares 10-Q · filed 2024-05-14 | |||
| 2023-09-30 | 75.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-29 | 198.33K shares 10-K · filed 2023-12-29 | ||
| 2023-06-30 | 123.33K shares 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |